Excessive accumulation of free fatty acids (FFA) in hepatocytes is the main characteristic of NAFLD that could enhance nuclear factor (NF)-κB binding to the fetuin-A promoter, causing an increase in the synthesis and secretion of fetuin-A (7). The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.